Evaluation of Biodegradable, Three-Dimensional Matrices for Tissue Engineering of Heart Valves

ASAIO Journal ◽  
2000 ◽  
Vol 46 (1) ◽  
pp. 107-110 ◽  
Author(s):  
Ralf Sodian ◽  
Simon P. Hoerstrup ◽  
Jason S. Sperling ◽  
David P. Martin ◽  
Sabine Daebritz ◽  
...  
ASAIO Journal ◽  
1999 ◽  
Vol 45 (2) ◽  
pp. 121
Author(s):  
R Sodian ◽  
S P Hoerstrup ◽  
J S Sperling ◽  
D P Martin ◽  
G Nollert ◽  
...  

2018 ◽  
Vol 5 (3) ◽  
pp. 69 ◽  
Author(s):  
Xinmei Wang ◽  
Mir Ali ◽  
Carla Lacerda

Since most of the body’s extracellular matrix (ECM) is composed of collagen and elastin, we believe the choice of these materials is key for the future and promise of tissue engineering. Once it is known how elastin content of ECM guides cellular behavior (in 2D or 3D), one will be able to harness the power of collagen-elastin microenvironments to design and engineer stimuli-responsive tissues. Moreover, the implementation of such matrices to promote endothelial-mesenchymal transition of primary endothelial cells constitutes a powerful tool to engineer 3D tissues. Here, we design a 3D collagen-elastin scaffold to mimic the native ECM of heart valves, by providing the strength of collagen layers, as well as elasticity. Valve interstitial cells (VICs) were encapsulated in the collagen-elastin hydrogels and valve endothelial cells (VECs) cultured onto the surface to create an in vitro 3D VEC-VIC co-culture. Over a seven-day period, VICs had stable expression levels of integrin β1 and F-actin and continuously proliferated, while cell morphology changed to more elongated. VECs maintained endothelial phenotype up to day five, as indicated by low expression of F-actin and integrin β1, while transformed VECs accounted for less than 7% of the total VECs in culture. On day seven, over 20% VECs were transformed to mesenchymal phenotype, indicated by increased actin filaments and higher expression of integrin β1. These findings demonstrate that our 3D collagen-elastin scaffolds provided a novel tool to study cell-cell or cell-matrix interactions in vitro, promoting advances in the current knowledge of valvular endothelial cell mesenchymal transition.


2009 ◽  
Vol 42 (1) ◽  
pp. 49-53 ◽  
Author(s):  
P.K. Schaefermeier ◽  
D. Szymanski ◽  
F. Weiss ◽  
P. Fu ◽  
T. Lueth ◽  
...  

ASAIO Journal ◽  
2002 ◽  
Vol 48 (6) ◽  
pp. 586-591 ◽  
Author(s):  
Markus Rothenburger ◽  
Wolfgang Völker ◽  
Peter Vischer ◽  
Elmar Berendes ◽  
Birgit Glasmacher ◽  
...  

2007 ◽  
Vol 55 (S 1) ◽  
Author(s):  
R Sodian ◽  
D Rassoulian ◽  
H Mair ◽  
I Kaczmarek ◽  
B Reichart ◽  
...  

2013 ◽  
Vol 1 (1) ◽  
pp. 52-55 ◽  
Author(s):  
A. Popandopulo ◽  
M. Petrova

In many cases heart valve prosthetics is the only solution to save patient’s life. All mechanical prosthetics currently used are not able to perform function in the body fully because non-living materials are used for their production. Tissue engineering provides the reconstruction of viable valves using stem cells. Acellularized three-dimensional tissue scaffolds as a matrix for autologous cells do improve function of heart valves and promote heart regeneration.


2014 ◽  
Vol 5 (4) ◽  
pp. 318-322 ◽  
Author(s):  
S. M. Barinov ◽  
I. V. Vakhrushev ◽  
A. A. Egorov ◽  
V. S. Komlev ◽  
V. N. Kortunov ◽  
...  

2018 ◽  
Vol 24 (1) ◽  
pp. 70-78 ◽  
Author(s):  
Shiqing Zhang ◽  
Haibin Wang

Tissue engineering has progressed tremendously over recent decades through the generation of functional tissue analogs. Traditional approaches based on seeding cells into scaffold are limited in their capacity to produce tissues with precise biomimetic properties. Three-dimensional (3D) bioprinting is one kind of fabrication technology used to precisely dispense cell-laden biomaterials for the construction of functional tissues or organs. In recent years, much research progress has been made in 3D bioprinting technology and its application in generating tissue analogs, including skin, heart valves, blood vessels, bone, and cardiac tissue. However, it still faces many technical challenges. In this review, we introduce the current progress in 3D bioprinting technology and focus on biomaterials and their potential applications in regenerative medicine and drug discovery. Current challenges are also discussed.


Sign in / Sign up

Export Citation Format

Share Document